Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Frates James M sold 10,810 Amylyx Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 10, 2026 · Filed Sep 14, 2026
On Sep 10, 2026, Frates James M (Chief Financial Officer) sold 10,810 Amylyx Pharmaceuticals, Inc. shares at an average US$32.36 for US$350K, leaving 233,625 shares. Filed Sep 14, 2026 (Form 4).
- Sold
- 10,810 shares
- Price
- US$32.36 average (US$32.27 to US$33.23)
- Value
- US$350K
- Holding after
- 233,625 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Common Stock | Sale | 9,768 | US$32.27 | 234,667 | Direct |
| Sep 10, 2026 | Common Stock | Sale | 1,042 | US$33.23 | 233,625 | Direct |
Source
Related
- Amylyx Pharmaceuticals, Inc.
- Frates James M
- Amylyx Pharmaceuticals, Inc. shareholders
- Form 4 · Frates James M · Aug 20, 2026
- Form 4 · Milne George M Jr · Oct 7, 2026
- Form 4 · Bedrosian Camille L · Sep 14, 2026
- Form 4 · Mazzariello Gina · Sep 14, 2026
- Form 4 · Cohen Joshua B · Sep 14, 2026
- Form 4 · Klee Justin B. · Sep 14, 2026